戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 changes in the conformation of gp120 and the antibody binding site.
2 d amino acid residues positioned outside the antibody binding site.
3  temperature and distal residues outside the antibody binding site.
4 peptides come close to each other to form an antibody-binding site.
5 s exposing the amino acid side chains of the antibody binding sites.
6 tory HA mutations can be located in distinct antibody binding sites.
7 wly identified sites not located in reported antibody binding sites.
8 ry that included CDR3 engineered to optimize antibody binding sites.
9                This region may have multiple antibody binding sites.
10 croscopic images of immunocomplexes show two antibody binding sites.
11 performance because of large numbers of free antibody binding sites.
12  4000-fold faster inactivation at 4.2 microM antibody binding sites.
13 analyte-tracer and the analyte (HSA) for the antibody binding sites.
14  mutations that truncate ATM upstream of the antibody binding sites.
15 H/gL/gO-, and Pentamer-specific neutralizing antibody binding sites.
16 ty and therefore are potentially part of the antibody binding sites.
17 f epidemic H3 strains were mainly located in antibody-binding sites A and B as compared with TX/12e.
18 determine the number of CD4, CCR5, and CXCR4 antibody-binding sites (ABS) on various T cell lines, T
19 human intestine expressed CD4 (14,530+/-7970 antibody-binding sites [ABSs]/cell), CCR5 (2730+/-1524 A
20  through an indirect interaction between the antibody binding site and the L1 loop (amino acids 112-1
21 tides and carbohydrates can bind to the same antibody-binding site and that peptides can structurally
22    Neither of these mutations lies within an antibody-binding site, and therefore the mechanism of im
23 regulatory region for DNA binding and PAb421 antibody binding site are replaced, and p53as is constit
24 ly employ this strategy since the individual antibody binding sites are not arranged with appropriate
25 e thymidine uptake, which indicates that two antibody binding sites are required for activation.
26 ould induce a counter-charged residue in the antibody binding site at a locus suitable for it to depr
27          Mutations that are distant from the antibody binding site can lead to escape, probably by ch
28                               4) The loss of antibody binding sites caused by thrombin was due in par
29 ch to the development of chimeric bispecific antibody binding site (chi BABS) proteins.
30   An algorithm was developed to identify the antibody binding site class automatically based on the d
31 b) tailored amino acid composition mimicking antibody binding-site composition at putative paratope p
32 taining the 2F5/4E10 neutralizing monoclonal antibody binding sites, displays no detectable HIV-neutr
33 oid structures with 2-3 amino-terminal Abeta antibody binding sites, distinct from previously charact
34     These observations identify IC3.4 as the antibody binding site for sera of OCP patients and sugge
35 and ligands and have successfully modulated: antibody binding sites for antigen; antigen binding site
36 liminating the CD33 IgV domain, which is the antibody-binding site for GO, as well as diagnostic immu
37  the binding sites of empty and of complexed antibody binding sites gave an indication of how the sha
38                            The topography of antibody binding sites has been classified into five typ
39 ace plasmon resonance is used to identify an antibody binding site, HSA Peptide 40, on human serum al
40 ites identified in fibrillin-1, and on known antibody binding sites in fibrillin-1, a model is propos
41             Comparison of colloidal gold and antibody binding sites in untensioned microfibrils and t
42 nerates a comprehensive energetic map of the antibody-binding site in a facile and rapid manner and s
43 inal fragment of GRASP65, which contains the antibody binding site, into normal rat kidney cells prev
44 rticle and "intermediate" views, the primary antibody binding site is near the intersection between t
45                  Molecular identification of antibody binding sites may help to identify susceptible
46 itivity to the antibody, consistent with the antibody binding site observed by x-ray crystallography.
47 fusion results in a steady-state gradient of antibody binding site occupancy transverse to convective
48 ined that comprised most of the CDRs from an antibody binding site of interest.
49 gion of the human herpesvirus 8 (HHV-8), the antibody-binding site of glycoprotein K8.1A, was mapped
50              These studies have revealed the antibody binding site on human FasL.
51 1 (antigenic domain 1) represents a dominant antibody binding site on this protein.
52               Fibrinogen binding exposes new antibody binding sites on GPIIb-IIIa (ligand-induced bin
53 gest the location of additional neutralizing antibody binding sites on HCMV gB.
54 g assays suggested the existence of multiple antibody binding sites on melanin-concentrating hormone
55        To characterize the improved yield of antibody binding sites on such gold-coated phases, the m
56     However, comparison of distances between antibody binding sites on the recombinant peptides and l
57 emonstrates the exposure of key neutralizing antibody binding sites on the surface of the postfusion
58 pressed (approximately 1000-7000 STRL33 ABS [antibody binding sites]) on specific subsets of natural
59   A dye-labeled TNT analogue prebound in the antibody binding site quenches the QD photoluminescence
60 establish the stereochemical features in the antibody binding site that confer specificity for cocain
61                 One of these sequences is an antibody binding site that is used to inactivate phage c
62 inExA assay quantifies the fraction of total antibody binding sites that are unoccupied, regardless o
63 iscussed in the light of what is known about antibody binding sites, the high affinity of the 2C TCR,
64 ree-dimensional reconstructions revealed the antibody-binding sites to be on the so-called handle dom
65 s been used to measure the response of three antibody-binding sites to perturbation from electronic e
66 ctly quantitated by measuring the unoccupied antibody binding sites using a competing reporter.
67                                        A new antibody-binding site was discovered on the C-terminal a
68                        To define further the antibody binding site, we used random peptide phage disp
69 ructural model of this major epitope and its antibody binding site, which is independent of pH-induce

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。